🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 29/09/1975 | 1,88 | 1,89 | 1,80 | 1,82 | -3,52% | 4,75% | 1.995.811 |
| 26/09/1975 | 1,83 | 1,91 | 1,83 | 1,88 | +7,99% | 4,17% | 6.217.574 |
| 25/09/1975 | 1,75 | 1,77 | 1,74 | 1,74 | -0,57% | 1,51% | 1.082.794 |
| 24/09/1975 | 1,75 | 1,78 | 1,74 | 1,75 | +0,19% | 2,28% | 3.652.070 |
| 23/09/1975 | 1,79 | 1,79 | 1,73 | 1,75 | -3,12% | 3,51% | 5.791.248 |
| 22/09/1975 | 1,88 | 1,88 | 1,80 | 1,81 | -3,71% | 4,24% | 1.909.037 |
| 19/09/1975 | 1,82 | 1,88 | 1,82 | 1,88 | +3,67% | 3,29% | 1.561.939 |
| 18/09/1975 | 1,77 | 1,81 | 1,77 | 1,81 | +2,05% | 2,25% | 1.124.294 |
| 17/09/1975 | 1,75 | 1,78 | 1,75 | 1,77 | +1,33% | 1,89% | 599.875 |
| 16/09/1975 | 1,77 | 1,78 | 1,75 | 1,75 | -1,31% | 1,87% | 1.045.066 |
| 15/09/1975 | 1,77 | 1,77 | 1,75 | 1,77 | +0,19% | 1,12% | 596.102 |
| 12/09/1975 | 1,77 | 1,79 | 1,76 | 1,77 | +0,00% | 1,68% | 769.651 |
| 11/09/1975 | 1,77 | 1,79 | 1,75 | 1,77 | +0,00% | 2,43% | 1.086.566 |
| 10/09/1975 | 1,77 | 1,77 | 1,74 | 1,77 | -1,11% | 2,06% | 1.701.533 |
| 09/09/1975 | 1,83 | 1,83 | 1,78 | 1,79 | -2,18% | 2,90% | 2.093.904 |
| 08/09/1975 | 1,83 | 1,85 | 1,82 | 1,83 | +0,18% | 1,45% | 667.786 |
| 05/09/1975 | 1,84 | 1,84 | 1,82 | 1,83 | -1,25% | 1,44% | 962.064 |
| 04/09/1975 | 1,83 | 1,86 | 1,83 | 1,85 | +0,91% | 1,63% | 1.105.430 |
| 03/09/1975 | 1,84 | 1,84 | 1,81 | 1,83 | -0,90% | 1,26% | 747.014 |
| 02/09/1975 | 1,86 | 1,87 | 1,82 | 1,85 | -0,71% | 2,49% | 1.056.384 |
| 29/08/1975 | 1,88 | 1,88 | 1,85 | 1,86 | -0,71% | 1,59% | 1.460.074 |
| 28/08/1975 | 1,86 | 1,88 | 1,86 | 1,88 | +1,43% | 1,43% | 909.245 |
| 27/08/1975 | 1,83 | 1,87 | 1,82 | 1,85 | +1,09% | 2,35% | 1.033.747 |
| 26/08/1975 | 1,87 | 1,88 | 1,83 | 1,83 | -2,12% | 2,84% | 1.180.886 |
| 25/08/1975 | 1,84 | 1,88 | 1,84 | 1,87 | +2,36% | 1,80% | 1.011.110 |
| 22/08/1975 | 1,82 | 1,84 | 1,80 | 1,83 | +0,18% | 1,82% | 1.135.613 |
| 21/08/1975 | 1,84 | 1,85 | 1,80 | 1,82 | -1,07% | 2,52% | 2.912.602 |
| 20/08/1975 | 1,86 | 1,88 | 1,84 | 1,84 | -0,72% | 2,15% | 1.373.299 |
| 19/08/1975 | 1,88 | 1,88 | 1,86 | 1,86 | -1,75% | 1,41% | 652.694 |
| 18/08/1975 | 1,90 | 1,90 | 1,88 | 1,89 | -0,53% | 1,22% | 830.016 |